de Freitas Cayres LC, de Salis LVV, Rodrigues GSP, van Lengert AH, Biondi APC, Sargentini LDB et al (2021) Detection of alterations in the gut microbiota and intestinal permeability in patients with Hashimoto thyroiditis
(Source: Applied Clinical Trials, 2026) Weight Loss Progress Over Time STEP-1 Trial Related at GoalBMI Wellness Semaglutide & Cardiovascular Health SELECT Trial Data Beyond weight loss, the 2023 SELECT (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) trial established semaglutide as a cardiovascular medication a landmark finding that expanded its clinical use far beyond obesity treatment
Last Published 07.17.2026 Effective Date: 07.01.2026 This policy addresses transcatheter heart valve (aortic, pulmonary, mitral) procedures
Zepbounds Role in Weight Management The clinical trials for Zepbound have demonstrated remarkable results in weight reduction
Compliance-first sales policy
337,338,339,340 For example, Kaban et al